Literature DB >> 16179222

X chromosome array-CGH for the identification of novel X-linked mental retardation genes.

Marijke Bauters1, Hilde Van Esch, Peter Marynen, Guy Froyen.   

Abstract

Array-CGH technology for the detection of submicroscopic copy number changes in the genome has recently been developed for the identification of novel disease-associated genes. It has been estimated that submicroscopic genomic deletions or duplications will be present in 5-7% of patients with idiopathic mental retardation (MR). Since 30% more males than females are diagnosed with MR, we have developed a full coverage X chromosome array-CGH with a theoretical resolution of 82 kb, for the detection of copy number alterations in patients with suspected X-linked mental retardation (XLMR). First, we have validated the genomic location of X-derived clones through male versus female hybridisations. Next, we validated our array for efficient and reproducible detection of known alterations in XLMR patients. In all cases, we were able to detect the deletions and duplications in males as well as females. Due to the high resolution of our X-array, the boundaries of the genomic aberrations could clearly be identified making genotype-phenotype studies more reliable. Here, we describe the production and validation of a full coverage X-array-CGH, which will allow for fast and easy screening of submicroscopic copy number alterations in XLMR patients with the aim to identify novel MR genes or mechanisms involved in a deranged cognitive development.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16179222     DOI: 10.1016/j.ejmg.2005.04.008

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  15 in total

1.  High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping.

Authors:  Daniel A Peiffer; Jennie M Le; Frank J Steemers; Weihua Chang; Tony Jenniges; Francisco Garcia; Kirt Haden; Jiangzhen Li; Chad A Shaw; John Belmont; Sau Wai Cheung; Richard M Shen; David L Barker; Kevin L Gunderson
Journal:  Genome Res       Date:  2006-08-09       Impact factor: 9.043

2.  Array comparative genomic hybridisation analysis of boys with X-linked hypopituitarism identifies a 3.9 Mb duplicated critical region at Xq27 containing SOX3.

Authors:  Nicola M Solomon; Shelley A Ross; Susan M Forrest; Paul Q Thomas; Thomas Morgan; Joseph L Belsky; Frans A Hol; Pamela S Karnes; Nancy J Hopwood; Susan E Myers; Anjanette S Tan; Garry L Warne
Journal:  J Med Genet       Date:  2007-04       Impact factor: 6.318

3.  Comparison of comparative genomic hybridization technologies across microarray platforms.

Authors:  Susan D Hester; Laura Reid; Norma Nowak; Wendell D Jones; Joel S Parker; Kevin Knudtson; William Ward; Jay Tiesman; Nancy D Denslow
Journal:  J Biomol Tech       Date:  2009-04

4.  X-linked congenital ptosis and associated intellectual disability, short stature, microcephaly, cleft palate, digital and genital abnormalities define novel Xq25q26 duplication syndrome.

Authors:  R S Møller; L R Jensen; S M Maas; J Filmus; M Capurro; C Hansen; C L M Marcelis; K Ravn; J Andrieux; M Mathieu; M Kirchhoff; O K Rødningen; N de Leeuw; H G Yntema; G Froyen; J Vandewalle; K Ballon; E Klopocki; S Joss; J Tolmie; A C Knegt; A M Lund; H Hjalgrim; A W Kuss; N Tommerup; R Ullmann; A P M de Brouwer; P Strømme; S Kjaergaard; Z Tümer; T Kleefstra
Journal:  Hum Genet       Date:  2013-12-11       Impact factor: 4.132

5.  Dosage-dependent severity of the phenotype in patients with mental retardation due to a recurrent copy-number gain at Xq28 mediated by an unusual recombination.

Authors:  Joke Vandewalle; Hilde Van Esch; Karen Govaerts; Jelle Verbeeck; Christiane Zweier; Irene Madrigal; Montserrat Mila; Elly Pijkels; Isabel Fernandez; Jürgen Kohlhase; Christiane Spaich; Anita Rauch; Jean-Pierre Fryns; Peter Marynen; Guy Froyen
Journal:  Am J Hum Genet       Date:  2009-12       Impact factor: 11.025

6.  Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males.

Authors:  Hilde Van Esch; Marijke Bauters; Jaakko Ignatius; Mieke Jansen; Martine Raynaud; Karen Hollanders; Dorien Lugtenberg; Thierry Bienvenu; Lars Riff Jensen; Jozef Gecz; Claude Moraine; Peter Marynen; Jean-Pierre Fryns; Guy Froyen
Journal:  Am J Hum Genet       Date:  2005-07-29       Impact factor: 11.025

7.  A new chromosome x exon-specific microarray platform for screening of patients with X-linked disorders.

Authors:  Stavros Bashiardes; Ludmila Kousoulidou; Hans van Bokhoven; Hans-Hilger Ropers; Jamel Chelly; Claude Moraine; Arjan P M de Brouwer; Hilde Van Esch; Guy Froyen; Philippos C Patsalis
Journal:  J Mol Diagn       Date:  2009-09-24       Impact factor: 5.568

8.  Nonrecurrent MECP2 duplications mediated by genomic architecture-driven DNA breaks and break-induced replication repair.

Authors:  Marijke Bauters; Hilde Van Esch; Michael J Friez; Odile Boespflug-Tanguy; Martin Zenker; Angela M Vianna-Morgante; Carla Rosenberg; Jaakko Ignatius; Martine Raynaud; Karen Hollanders; Karen Govaerts; Kris Vandenreijt; Florence Niel; Pierre Blanc; Roger E Stevenson; Jean-Pierre Fryns; Peter Marynen; Charles E Schwartz; Guy Froyen
Journal:  Genome Res       Date:  2008-04-02       Impact factor: 9.043

9.  Familial interstitial Xq27.3q28 duplication encompassing the FMR1 gene but not the MECP2 gene causes a new syndromic mental retardation condition.

Authors:  Marlène Rio; Valérie Malan; Sarah Boissel; Annick Toutain; Ghislaine Royer; Stéphanie Gobin; Nicole Morichon-Delvallez; Catherine Turleau; Jean-Paul Bonnefont; Arnold Munnich; Michel Vekemans; Laurence Colleaux
Journal:  Eur J Hum Genet       Date:  2009-10-21       Impact factor: 4.246

10.  Emerging patterns of cryptic chromosomal imbalance in patients with idiopathic mental retardation and multiple congenital anomalies: a new series of 140 patients and review of published reports.

Authors:  B Menten; N Maas; B Thienpont; K Buysse; J Vandesompele; C Melotte; T de Ravel; S Van Vooren; I Balikova; L Backx; S Janssens; A De Paepe; B De Moor; Y Moreau; P Marynen; J-P Fryns; G Mortier; K Devriendt; F Speleman; J R Vermeesch
Journal:  J Med Genet       Date:  2006-02-20       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.